Heterozygous mutations in GARS1, the gene encoding glycyl-tRNA synthetase (GlyRS), give rise to an axonal form of CMT, type 2D (CMT2D) [1, 5]. The gene discussed is GARS1; the disease is Charcot-Marie-Tooth disease.